← RIGEL PHARMACEUTICALS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $17.6m | $38.3m | $76.3m | $22.5m | $30.4m | $18.9m | $24.5m | $32.8m | $56.7m | $40.6m | |
| Prepaid Expense and Other Assets, Current | $1.4m | $1.7m | $3.5m | $9.5m | $14.0m | $7.4m | $8.3m | $6.3m | $10.2m | $21.9m | |
| Cash, Cash Equivalents, and Short-term Investments | $74.8m | $115.8m | $128.5m | $98.1m | $57.3m | $125.0m | $58.2m | $56.9m | $77.3m | $155.0m | |
| Short-term Investments | $57.1m | $77.5m | $52.2m | $75.6m | $27.0m | $106.1m | $33.7m | $24.1m | $20.6m | $114.4m | |
| Inventory, Net | — | — | $894k | $1.4m | $1.6m | $6.6m | $9.1m | $5.5m | $6.0m | $11.5m | |
| Assets, Current | $76.2m | $117.4m | $137.0m | $119.0m | $89.0m | $154.5m | $115.9m | $99.3m | $135.1m | $240.2m | |
| Property, Plant and Equipment, Net | $1.2m | $875k | $1.4m | $2.2m | $2.7m | $2.2m | $857k | $165k | $92k | $30k | |
| Operating Lease, Right-of-Use Asset | — | — | — | $25.7m | $17.9m | $9.7m | $1.9m | $861k | $246k | $920k | |
| Other Assets, Noncurrent | $764k | $803k | $735k | $696k | $824k | $974k | $640k | $3.1m | $1.4m | $1.9m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $0 | $0 | $4.1m | $10.1m | $16.0m | $15.5m | $40.3m | $30.6m | $41.6m | $51.8m | |
| Accrued Liabilities, Current | — | — | — | — | $3.7m | $3.6m | — | — | — | — | |
| Assets | $78.1m | $119.1m | $139.1m | $147.6m | $110.4m | $167.3m | $134.3m | $117.2m | $164.0m | $513.6m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $7.3m | $8.6m | $9.9m | $1.1m | $692k | $285k | $614k | |
| Accounts Payable, Current | $5.6m | $2.6m | $6.4m | $4.2m | $3.7m | $3.8m | $22.5m | $7.1m | $3.3m | $7.2m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $19.2m | $10.7m | $759k | $972k | $285k | — | $395k | |
| Liabilities, Current | $22.6m | $18.3m | $27.7m | $58.2m | $40.8m | $63.6m | $65.2m | $53.3m | $63.3m | $99.2m | |
| Other Liabilities, Noncurrent | $2k | $38k | — | $5.1m | $5.0m | $52.7m | $42.3m | $39.9m | $40.0m | $0 | |
| Long-term Debt | — | — | — | $10.0m | $20.0m | $20.0m | $40.0m | $60.0m | $60.0m | $52.5m | |
| Liabilities | — | — | — | — | — | — | $147.9m | $145.9m | $160.7m | $122.1m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | — | — | — | — | — | — | — | — | $0 | $0 | |
| Common Stock, Value, Issued | $100k | $147k | $167k | $168k | $169k | $172k | $174k | $175k | $18k | $18k | |
| Retained Earnings (Accumulated Deficit) | ($1.1b) | ($1.1b) | ($1.2b) | ($1.3b) | ($1.3b) | ($1.3b) | ($1.4b) | ($1.4b) | ($1.4b) | ($1.0b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($18k) | ($82k) | ($24k) | $23k | ($4k) | ($102k) | ($153k) | $8k | $10k | $181k | |
| Additional Paid in Capital, Common Stock | $1.1b | $1.2b | $1.3b | $1.3b | $1.3b | $1.4b | $1.4b | $1.4b | $1.4b | $1.4b | |
| Stockholders' Equity Attributable to Parent | $55.0m | $100.6m | $109.9m | $53.8m | $34.0m | $30.4m | ($13.6m) | ($28.6m) | $3.3m | $391.5m | |
| Liabilities and Equity | $78.1m | $119.1m | $139.1m | $147.6m | $110.4m | $167.3m | $134.3m | $117.2m | $164.0m | $513.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.